Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)CIOMEI, M; PASTORI, W; CAPOLONGO, L et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1504-1508, issn 0007-0920Article

In vitro activity of novel sulphonic derivatives of distamicyn AMARIANI, M; PAIO, A; CIOMEI, M et al.Experientia. Supplementum. 1992, Num 61, pp 455-458, issn 0071-335XArticle

Reversal of multidrug resistance by new dihydropyridines with low calcium antagonist activityCAPOLONGO, L; AMBOLDI, N; BALLINARI, D et al.Acta oncologica (Stockholm). 1994, Vol 33, Num 7, pp 787-791, issn 0284-186XConference Paper

Morpholinylanthracyclines : cytotoxicity and antitumor activity of differently modified derivativesRIPAMONTI, M; CAPOLONGO, L; MELEGARO, G et al.Investigational new drugs. 1996, Vol 14, Num 2, pp 139-146, issn 0167-6997Article

Temperature influences both cytotoxicity and DNA nicking efficiency of the antitumor distamycin analogue FCE24517MONTECUCCO, A; CAPOLONGO, L; MELEGARO, G et al.Anticancer research. 1994, Vol 14, Num 1A, pp 189-192, issn 0250-7005Article

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517)CAPOLONGO, L; MELEGARO, G; BROGGINI, M et al.British journal of cancer. 1993, Vol 68, Num 5, pp 916-919, issn 0007-0920Article